Avstralija -
angleščina -
Department of Health (Therapeutic Goods Administration)
stelara ustekinumab 45 mg/0.5 ml solution for injection vial
janssen-cilag pty ltd - ustekinumab, quantity: 45 mg - injection, solution - excipient ingredients: histidine; polysorbate 80; histidine hydrochloride monohydrate; water for injections; sucrose - plaque psoriasis,adults - stelara is indicated for the treatment of adult patients (18 years or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.,paediatric population, 6 years and older - stelara is indicated for the treatment of moderate to severe plaque psoriasis in children and adolescent patients from 6 years of age who are inadequately controlled by, or are intolerant to, other systemic therapies or phototherapies.,psoriatic arthritis (psa),stelara, alone or in combination with methotrexate, is indicated for the treatment of signs and symptoms of active psoriatic arthritis in adult patients (18 years and older) where response to previous non-biological dmard therapy has been inadequate.,crohn?s disease,stelara is indicated for the treatment of adult patients with moderately to severely active crohn?s disease who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a tnf alpha antagonist or have medical contraindications to such therapies.,ulcerative colitis,stelara is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis.
Velika Britanija -
angleščina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
engerix b 20micrograms/1ml vaccine suspension for injection vials
glaxosmithkline uk ltd - hepatitis b virus surface antigen - suspension for injection - 20microgram/1ml
Velika Britanija -
angleščina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
engerix b 10micrograms/0.5ml vaccine suspension for injection vials
glaxosmithkline uk ltd - hepatitis b virus surface antigen - suspension for injection - 20microgram/1ml
Velika Britanija -
angleščina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
engerix b 20micrograms/1ml vaccine suspension for injection pre-filled syringes
glaxosmithkline uk ltd - hepatitis b virus surface antigen - suspension for injection - 20microgram/1ml
Velika Britanija -
angleščina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
engerix b 10micrograms/0.5ml vaccine suspension for injection pre-filled syringes
glaxosmithkline uk ltd - hepatitis b virus surface antigen - suspension for injection - 20microgram/1ml
Belgija -
angleščina -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
bcg-medac i.vesic. susp. (pwdr. + solv.) vial
medac gmbh - mycobacterium tuberculosi (= bcg) (= bacillus calmette-guerin) 2 10*8 cfu/dose - 3 10*9 cfu/dose - powder and solvent for intravesical suspension - tuberculins (bcg) - bcg vaccine
Singapur -
angleščina -
HSA (Health Sciences Authority)
remsima solution for subcutaneous injection 120 mgml in pre-filled pen
celltrion healthcare singapore private limited - infliximab - injection, solution - infliximab 120mg/ml
Singapur -
angleščina -
HSA (Health Sciences Authority)
remsima solution for subcutaneous injection 120 mgml in pre-filled syringe
celltrion healthcare singapore private limited - infliximab - injection, solution - infliximab 120mg/ml
Malezija -
angleščina -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
sii-onco-bcg (powder for intravesical instillation) bcg live usp. 1 vial of 40 mg/ml
radiantaire sdn bhd - bcg live -
Avstralija -
angleščina -
Department of Health (Therapeutic Goods Administration)
bcg vaccine
sanofi-aventis australia pty ltd - bacillus calmette and guerin -